Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Cohn

Showing results (231-240 of 302) with videos related to

Pageof 31
Sort By:
Frontiers in Genetics|June 6, 2022
Genetic and Epigenetic Mechanisms Deregulate the CRL2<sup>pVHL</sup> Complex in Hepatocellular CarcinomaBrenda C Minatel, David E Cohn, Michelle E Pewarchuk, et al.
Gynecologic Oncology|June 26, 2020
Patient reported outcomes measures in gynecologic oncology: A primer for clinical use, part IRachel C Sisodia, Summer B Dewdney, Amanda N Fader, et al.
Gynecologic Oncology|June 26, 2020
Patient reported outcomes measures in gynecologic oncology: A primer for clinical use, Part IIRachel C Sisodia, Summer B Dewdney, Amanda N Fader, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2010
REO-10: a phase I study of intravenous reovirus and docetaxel in patients with advanced cancerCharles Comins, James Spicer, Andrew Protheroe, et al.
Gynecologic Oncology|June 1, 2025
The impact of antibiotics, proton pump inhibitors, H2-receptor antagonists, and steroids on survival in ovarian cancer patients receiving PARP inhibitor therapyQuinn Kistenfeger, Paulina J Haight, Monica Levine, et al.
Gynecologic Oncology|December 17, 2003
Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapyWarner K Huh, Matthew Powell, Charles A Leath, et al.
Gynecologic Oncology|May 5, 2012
Minimally invasive surgery versus laparotomy in women with high grade endometrial cancer: a multi-site study performed at high volume cancer centersAmanda Nickles Fader, Leigh G Seamon, Pedro F Escobar, et al.
Gynecologic Oncology|September 23, 2023
The impact of antibiotic and proton pump inhibitor use at the time of adjuvant platinum-based chemotherapy on survival in patients with endometrial cancerPaulina J Haight, Quinn Kistenfeger, Courtney J Riedinger, et al.
Human Mutation|June 28, 2016
MonoSeq Variant Caller Reveals Novel Mononucleotide Run Indel Mutations in Tumors with Defective DNA Mismatch RepairChristopher J Walker, Mario A Miranda, Matthew J O'Hern, et al.
Gynecologic Oncology|September 6, 2015
Associations between etiologic factors and mortality after endometrial cancer diagnosis: the NRG Oncology/Gynecologic Oncology Group 210 trialAshley S Felix, D Scott McMeekin, David Mutch, et al.
Pageof 31

Showing results (231-240 of 302) with videos related to

Sort By:
Pageof 31
Frontiers in Genetics|June 6, 2022
Genetic and Epigenetic Mechanisms Deregulate the CRL2<sup>pVHL</sup> Complex in Hepatocellular CarcinomaBrenda C Minatel, David E Cohn, Michelle E Pewarchuk, et al.
Gynecologic Oncology|June 26, 2020
Patient reported outcomes measures in gynecologic oncology: A primer for clinical use, part IRachel C Sisodia, Summer B Dewdney, Amanda N Fader, et al.
Gynecologic Oncology|June 26, 2020
Patient reported outcomes measures in gynecologic oncology: A primer for clinical use, Part IIRachel C Sisodia, Summer B Dewdney, Amanda N Fader, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2010
REO-10: a phase I study of intravenous reovirus and docetaxel in patients with advanced cancerCharles Comins, James Spicer, Andrew Protheroe, et al.
Gynecologic Oncology|June 1, 2025
The impact of antibiotics, proton pump inhibitors, H2-receptor antagonists, and steroids on survival in ovarian cancer patients receiving PARP inhibitor therapyQuinn Kistenfeger, Paulina J Haight, Monica Levine, et al.
Gynecologic Oncology|December 17, 2003
Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapyWarner K Huh, Matthew Powell, Charles A Leath, et al.
Gynecologic Oncology|May 5, 2012
Minimally invasive surgery versus laparotomy in women with high grade endometrial cancer: a multi-site study performed at high volume cancer centersAmanda Nickles Fader, Leigh G Seamon, Pedro F Escobar, et al.
Gynecologic Oncology|September 23, 2023
The impact of antibiotic and proton pump inhibitor use at the time of adjuvant platinum-based chemotherapy on survival in patients with endometrial cancerPaulina J Haight, Quinn Kistenfeger, Courtney J Riedinger, et al.
Human Mutation|June 28, 2016
MonoSeq Variant Caller Reveals Novel Mononucleotide Run Indel Mutations in Tumors with Defective DNA Mismatch RepairChristopher J Walker, Mario A Miranda, Matthew J O'Hern, et al.
Gynecologic Oncology|September 6, 2015
Associations between etiologic factors and mortality after endometrial cancer diagnosis: the NRG Oncology/Gynecologic Oncology Group 210 trialAshley S Felix, D Scott McMeekin, David Mutch, et al.
Pageof 31